Metastatic Adenocarcinoma of the Pancreas - Pipeline Review, H1 2013 - New Study Released
Global Markets Direct's, 'Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Adenocarcinoma of The Pancreas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Adenocarcinoma of The Pancreas. Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, Half Year is built using data and information sourced...
View full press release